BD, Gen-Probe Settle Patent Dispute | GenomeWeb

NEW YORK (GenomeWeb News) – Becton Dickinson said today that it and Hologic's Gen-Probe business have settled a patent dispute, and the company has been granted a license from Gen-Probe to make, use, and sell certain products that BD had been accused of infringing.

BD will make payments to Gen-Probe as part of the settlement, including upfront fees and ongoing royalties. BD did not specify the amounts of the payments but said they are not material to the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.